$TNXP
Tonix Pharmaceuticals Holding Corp.

2014 Q4 Form 10-Q Financial Statement

#000114420414066098 Filed on November 07, 2014

View on sec.gov

Income Statement

Concept 2014 Q4 2014 Q3 2013 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.230M $2.220M $1.450M
YoY Change 35.71% 53.1% 34.26%
% of Gross Profit
Research & Development $5.780M $5.217M $1.637M
YoY Change 334.59% 218.69% 148.03%
% of Gross Profit
Depreciation & Amortization $20.00K $10.00K $0.00
YoY Change 100.0%
% of Gross Profit
Operating Expenses $9.000M $7.434M $3.092M
YoY Change 142.59% 140.43% 78.73%
Operating Profit -$9.004M -$7.434M -$3.092M
YoY Change 140.43%
Interest Expense $20.00K $20.00K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$8.990M -$7.420M -$3.090M
YoY Change 142.32% 140.13% 78.61%
Income Tax
% Of Pretax Income
Net Earnings -$8.989M -$7.419M -$3.090M
YoY Change 142.29% 140.1% 78.61%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$899.0M -$742.0M -$873.5M
COMMON SHARES
Basic Shares Outstanding 10.77M shares 10.59M shares 4.877M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q4 2014 Q3 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $38.20M $46.20M $7.400M
YoY Change 365.85% 524.32%
Cash & Equivalents $38.18M $46.23M $7.400M
Short-Term Investments
Other Short-Term Assets $900.0K $700.0K $0.00
YoY Change 125.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $39.04M $46.90M $7.500M
YoY Change 352.28% 525.33% 7400.0%
LONG-TERM ASSETS
Property, Plant & Equipment $328.0K $200.0K $0.00
YoY Change 628.89% -100.0%
Goodwill
YoY Change
Intangibles $0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets $200.0K $200.0K $100.0K
YoY Change 100.0% 100.0% 0.0%
Total Long-Term Assets $506.0K $428.0K $100.0K
YoY Change 381.9% 328.0% 0.0%
TOTAL ASSETS
Total Short-Term Assets $39.04M $46.90M $7.500M
Total Long-Term Assets $506.0K $428.0K $100.0K
Total Assets $39.54M $47.33M $7.600M
YoY Change 352.63% 522.74% 3700.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.487M $2.448M $1.000M
YoY Change 94.38% 144.8% 42.86%
Accrued Expenses $1.895M $1.049M $900.0K
YoY Change 62.52% 16.56% 800.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $300.0K
YoY Change -100.0% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.382M $3.497M $2.100M
YoY Change 52.96% 66.52% 162.5%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.0K $100.0K $0.00
YoY Change
Total Long-Term Liabilities $100.0K $100.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.382M $3.497M $2.100M
Total Long-Term Liabilities $100.0K $100.0K $0.00
Total Liabilities $3.450M $3.551M $2.100M
YoY Change 55.13% 69.1% 133.33%
SHAREHOLDERS EQUITY
Retained Earnings -$54.34M -$45.36M
YoY Change 103.32%
Common Stock $90.43M $89.13M
YoY Change 172.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $36.09M $43.78M $5.400M
YoY Change
Total Liabilities & Shareholders Equity $39.54M $47.33M $7.600M
YoY Change 352.63% 522.74% 3700.0%

Cashflow Statement

Concept 2014 Q4 2014 Q3 2013 Q3
OPERATING ACTIVITIES
Net Income -$8.989M -$7.419M -$3.090M
YoY Change 142.29% 140.1% 78.61%
Depreciation, Depletion And Amortization $20.00K $10.00K $0.00
YoY Change 100.0%
Cash From Operating Activities -$8.220M -$4.860M -$2.870M
YoY Change 132.86% 69.34% 120.77%
INVESTING ACTIVITIES
Capital Expenditures -$130.0K -$150.0K -$10.00K
YoY Change 1200.0% 1400.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities -$120.0K -$160.0K -$10.00K
YoY Change 1100.0% 1500.0% 0.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 310.0K 7.370M 10.22M
YoY Change -92.82% -27.89%
NET CHANGE
Cash From Operating Activities -8.220M -4.860M -2.870M
Cash From Investing Activities -120.0K -160.0K -10.00K
Cash From Financing Activities 310.0K 7.370M 10.22M
Net Change In Cash -8.030M 2.350M 7.340M
YoY Change -1129.49% -67.98% -660.31%
FREE CASH FLOW
Cash From Operating Activities -$8.220M -$4.860M -$2.870M
Capital Expenditures -$130.0K -$150.0K -$10.00K
Free Cash Flow -$8.090M -$4.710M -$2.860M
YoY Change 129.83% 64.69% 121.71%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
52914000 USD
CY2014Q3 us-gaap Security Deposit
SecurityDeposit
45000 USD
CY2014Q3 us-gaap Assets
Assets
47328000 USD
CY2014Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2448000 USD
CY2014Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1049000 USD
CY2014Q3 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
0 USD
CY2014Q3 us-gaap Liabilities Current
LiabilitiesCurrent
3497000 USD
CY2014Q3 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
54000 USD
CY2014Q3 us-gaap Liabilities
Liabilities
3551000 USD
CY2014Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q3 us-gaap Common Stock Value
CommonStockValue
11000 USD
CY2014Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
89120000 USD
CY2014Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45355000 USD
CY2014Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1000 USD
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
43777000 USD
CY2014Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
47328000 USD
CY2014Q3 tnxp Working Capital Amount
WorkingCapitalAmount
43400000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.0202 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.9996 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0.0 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0.0 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1275466 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2087801 USD
CY2013Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
441571 USD
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
883877 USD
CY2014Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1816932 shares
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
187500 USD
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
37723 USD
CY2013Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
62500 USD
CY2014Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0 USD
CY2014Q3 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
200000 USD
CY2014Q3 us-gaap Repayment Of Notes Receivable From Related Parties
RepaymentOfNotesReceivableFromRelatedParties
80000 USD
CY2014Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
47000 USD
CY2013Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
46000 USD
CY2014Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2013Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
491000 USD
CY2014Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2013Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2014Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10734043 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5823081 shares
CY2014Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10734043 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5823081 shares
CY2013Q4 tnxp Common Stock Shares To Be Issued
CommonStockSharesToBeIssued
11002 shares
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
106998 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
420120 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
445890 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
459295 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
540782 USD
CY2014Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
1973085 USD
CY2014Q3 us-gaap Other Commitment
OtherCommitment
13100000 USD
us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
74706 USD
CY2014Q3 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
44042 USD
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.19 pure
us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1 pure
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3322000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12842000 USD
CY2013Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1637000 USD
CY2014Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5217000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3857000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5810000 USD
CY2013Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1455000 USD
CY2014Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2217000 USD
us-gaap Operating Expenses
OperatingExpenses
7179000 USD
us-gaap Operating Expenses
OperatingExpenses
18652000 USD
CY2013Q3 us-gaap Operating Expenses
OperatingExpenses
3092000 USD
CY2014Q3 us-gaap Operating Expenses
OperatingExpenses
7434000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-7179000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-18652000 USD
CY2013Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3092000 USD
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7434000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
25000 USD
CY2013Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2000 USD
CY2014Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
15000 USD
us-gaap Net Income Loss
NetIncomeLoss
-7177000 USD
us-gaap Net Income Loss
NetIncomeLoss
-18627000 USD
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-3090000 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-7419000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.73
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.92
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.87
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.71
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
2632777 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
9719142 shares
CY2013Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
3537490 shares
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
10496504 shares
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-2000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
1000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
2000 USD
CY2013Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 USD
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7177000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-18625000 USD
tnxp Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
5358000 USD
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
40654000 USD
us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
608000 USD
us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
2088000 USD
us-gaap Depreciation
Depreciation
12000 USD
us-gaap Depreciation
Depreciation
15000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
30000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1276000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
2088000 USD
tnxp Issuance Of Common Stock To Intellectual Property
IssuanceOfCommonStockToIntellectualProperty
0 USD
tnxp Issuance Of Common Stock To Intellectual Property
IssuanceOfCommonStockToIntellectualProperty
608000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-178000 USD
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
268000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
160000 USD
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
1688000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-3000 USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
542000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-127000 USD
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
0 USD
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
45000 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-4000 USD
us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
46000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4986000 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-14622000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
194000 USD
us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
0 USD
us-gaap Increase In Restricted Cash
IncreaseInRestrictedCash
73000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-8000 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-267000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
280000 USD
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
307000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5358000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10042000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47836000 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
10629000 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Document Period End Date
DocumentPeriodEndDate
2014-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Registrant Name
EntityRegistrantName
Tonix Pharmaceuticals Holding Corp.
dei Entity Central Index Key
EntityCentralIndexKey
0001430306
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Trading Symbol
TradingSymbol
TNXP
CY2014Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
10771690 shares
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
280000 USD
us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
0 USD
us-gaap Effect Of Exchange Rate On Cash
EffectOfExchangeRateOnCash
0 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
5635000 USD
us-gaap Cash Period Increase Decrease
CashPeriodIncreaseDecrease
38025000 USD
CY2012Q4 us-gaap Cash
Cash
1785000 USD
CY2013Q3 us-gaap Cash
Cash
7420000 USD
us-gaap Interest Paid
InterestPaid
3000 USD
us-gaap Interest Paid
InterestPaid
0 USD
tnxp Stock Issued During Period Value In Exchange For Exercise Of Warrants On Cash Less Basis
StockIssuedDuringPeriodValueInExchangeForExerciseOfWarrantsOnCashLessBasis
0 USD
tnxp Stock Issued During Period Value Warrants Exercised1
StockIssuedDuringPeriodValueWarrantsExercised1
7182000 USD
tnxp Proceeds From Exercise Of Warrants
ProceedsFromExerciseOfWarrants
5400000 USD

Files In Submission

Name View Source Status
0001144204-14-066098-index-headers.html Edgar Link pending
0001144204-14-066098-index.html Edgar Link pending
0001144204-14-066098.txt Edgar Link pending
0001144204-14-066098-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tnxp-20140930.xml Edgar Link completed
tnxp-20140930.xsd Edgar Link pending
tnxp-20140930_cal.xml Edgar Link unprocessable
tnxp-20140930_def.xml Edgar Link unprocessable
tnxp-20140930_lab.xml Edgar Link unprocessable
tnxp-20140930_pre.xml Edgar Link unprocessable
v392713_10-q.htm Edgar Link pending
v392713_ex31-01.htm Edgar Link pending
v392713_ex31-02.htm Edgar Link pending
v392713_ex32-01.htm Edgar Link pending